Tag: HER2/CEA-targeted CAR-T

Home / HER2/CEA-targeted CAR-T

Categories

Orphan drug designation is given by FDA to CART T-Cell Therapy A2B530 for the treatment of colorectal cancer

In March 2024, a news release said that A2B530 (A2 Biotherapeutics), a CAR T-cell therapy, had been given Orphan Drug Designation to treat colorectal cancer that expresses carcinoembryonic antigen (C...
her2-cea-targeted-car-t

Scan the code